Hyperfine (HYPR) Change in Account Payables (2021 - 2026)
Hyperfine's (HYPR) quarterly Change in Account Payables came in at $504000.0 in Q1 2026, down 16.0% YoY from $600000.0 in Q1 2025, and up 123.74% on a QoQ basis from -$2.1 million in Q4 2025.
Hyperfine (HYPR) Change in Account Payables (2021 - 2026) Analysis & Trends
Hyperfine (HYPR) has 6 years of Change in Account Payables data on file, last reported at $504000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 16.0% year-over-year to $504000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$107000.0 (down 110.72% YoY) and the FY2025 annual result came in at -$11000.0, down 102.88% from the prior year.
- Change in Account Payables improved to $504000.0 in Q1 2026, from -$2.1 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.1 million in Q3 2025 to a low of -$2.1 million in Q4 2025.
- A 5-year average of -$33705.9 and a median of $3000.0 in 2023 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 4747.37% in 2024, down 29266.67% in 2024.
- Tracing HYPR's Change in Account Payables over 5 years: stood at -$459000.0 in 2022, then soared by 205.66% to $485000.0 in 2023, then slipped by 19.59% to $390000.0 in 2024, then tumbled by 644.36% to -$2.1 million in 2025, then jumped by 123.74% to $504000.0 in 2026.
- The last three Change in Account Payables figures came in at $504000.0 (Q1 2026), -$2.1 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Hyperfine | 89.83 Mn | 45.06 Mn | 1.98 Mn | -2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.11 Mn |
| Jun 30, 2026 | -2.11 Mn |
| Mar 31, 2026 | 504,000.00 |
| Mar 31, 2026 | 504,000.00 |
| Dec 31, 2025 | -2.12 Mn |
| Dec 31, 2025 | -2.12 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | -602,000.00 |
| Jun 30, 2025 | -602,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 390,000.00 |
| Dec 31, 2024 | 390,000.00 |
| Sep 30, 2024 | -875,000.00 |
| Sep 30, 2024 | -875,000.00 |
| Jun 30, 2024 | 883,000.00 |
| Jun 30, 2024 | 883,000.00 |
| Mar 31, 2024 | -16,000.00 |
| Mar 31, 2024 | -16,000.00 |